What does APOTHEEK KROONPLEIN do?

APOTHEEK KROONPLEIN is a logistics company in Antwerpen. Private Limited, started on 16 November 1989, 1 establishment.

What is the address of APOTHEEK KROONPLEIN?

The registered office of APOTHEEK KROONPLEIN is located at Kroonplein 47, 2170 Antwerpen.

Is APOTHEEK KROONPLEIN still active?

Yes. According to the CBE (31 October 2026) APOTHEEK KROONPLEIN is active, legal situation “Normale toestand”, started on 16 November 1989.

Is APOTHEEK KROONPLEIN registered on Peppol?

Yes, APOTHEEK KROONPLEIN is registered on the Peppol network with ID 0208:0440018823.

What is the enterprise number of APOTHEEK KROONPLEIN?

The enterprise number of APOTHEEK KROONPLEIN is BE0440018823.

When was APOTHEEK KROONPLEIN founded?

APOTHEEK KROONPLEIN was founded on 16 November 1989.

Who are the directors of APOTHEEK KROONPLEIN?

According to the 2024 annual accounts, the directors of APOTHEEK KROONPLEIN are: Govemed BV.

Is APOTHEEK KROONPLEIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 November 1989; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did APOTHEEK KROONPLEIN make in 2024?

APOTHEEK KROONPLEIN posted a profit after taxes of € 66,435 in financial year 2024.

What is the revenue of APOTHEEK KROONPLEIN?

As a small company, APOTHEEK KROONPLEIN is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 172,586.

How many employees does APOTHEEK KROONPLEIN have?

According to the 2024 annual accounts, APOTHEEK KROONPLEIN has 0.9 full-time equivalents (FTE).

Does APOTHEEK KROONPLEIN have a website?

Yes, APOTHEEK KROONPLEIN has a website at apotheekkroonplein.be.

APOTHEEK KROONPLEIN (Private Limited) - Antwerpen

Dossier APOTHEEK KROONPLEIN, printed on 31 October 2026 from databakkes.be/en/0440018823/apotheek-kroonplein. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

APOTHEEK KROONPLEIN from Antwerpen, company number BE0440018823, closed financial year 2024 with a result of € 66,435 after tax. For that financial year APOTHEEK KROONPLEIN recorded a gross margin of € 172,586 and equity of € 146,558. Compared with financial year 2023, the result moved from € 13,046 to € 66,435. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2025.

What it is worth Growing

€ 146,558

▲ 22% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 66,435

▲ € 53,389 vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 32,730

▲ 104% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 40,000 paid out

60 % of the profit went to the shareholders, mostly to GOVEMED (100 % of the shares). That is where the money ends up.

People and assets in 2024

Full-time equivalents

0.9

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 91,770

▼ 8% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2024

Bank debt

€ 52,813

▼ 2% vs 2023

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 46,474

▼ 4% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,136

▼ 27% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 107,811 Gross margin 2021: € 107,811 First fiscal year in the series	€ 119,876 Gross margin 2022: € 119,876 ▲ 11% vs 2021 (€ 107,811) Favourable step	€ 123,301 Gross margin 2023: € 123,301 ▲ 3% vs 2022 (€ 119,876) Favourable step	€ 172,586 Gross margin 2024: € 172,586 ▲ 40% vs 2023 (€ 123,301) Favourable step	▲ 40%
Profit after taxes	€ 51,563 Profit after taxes 2021: € 51,563 First fiscal year in the series	€ 27,444 Profit after taxes 2022: € 27,444 ▼ 47% vs 2021 (€ 51,563) Unfavourable step	€ 13,046 Profit after taxes 2023: € 13,046 ▼ 52% vs 2022 (€ 27,444) Unfavourable step	€ 66,435 Profit after taxes 2024: € 66,435 ▲ € 53,389 vs 2023 (€ 13,046) Favourable step	▲ € 53,389
Equity	€ 79,634 Equity 2021: € 79,634 First fiscal year in the series	€ 107,078 Equity 2022: € 107,078 ▲ 34% vs 2021 (€ 79,634) Favourable step	€ 120,124 Equity 2023: € 120,124 ▲ 12% vs 2022 (€ 107,078) Favourable step	€ 146,558 Equity 2024: € 146,558 ▲ 22% vs 2023 (€ 120,124) Favourable step	▲ 22%
Total debts	€ 109,121 Total debts 2021: € 109,121 First fiscal year in the series	€ 139,854 Total debts 2022: € 139,854 ▲ 28% vs 2021 (€ 109,121) Unfavourable step	€ 157,740 Total debts 2023: € 157,740 ▲ 13% vs 2022 (€ 139,854) Unfavourable step	€ 185,870 Total debts 2024: € 185,870 ▲ 18% vs 2023 (€ 157,740) Unfavourable step	▲ 18%
Cash	€ 9,807 Cash 2021: € 9,807 First fiscal year in the series	€ 9,228 Cash 2022: € 9,228 ▼ 6% vs 2021 (€ 9,807) Unfavourable step	€ 16,083 Cash 2023: € 16,083 ▲ 74% vs 2022 (€ 9,228) Favourable step	€ 32,730 Cash 2024: € 32,730 ▲ 104% vs 2023 (€ 16,083) Favourable step	▲ 104%
Retained profit	€ 61,042 Retained profit 2021: € 61,042 First fiscal year in the series	€ 88,486 Retained profit 2022: € 88,486 ▲ 45% vs 2021 (€ 61,042) Favourable step	€ 101,532 Retained profit 2023: € 101,532 ▲ 15% vs 2022 (€ 88,486) Favourable step	€ 127,966 Retained profit 2024: € 127,966 ▲ 26% vs 2023 (€ 101,532) Favourable step	▲ 26%
Dividend	€ 35,000 Dividend 2021: € 35,000 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 35,000) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 40,000 Dividend 2024: € 40,000 Unchanged (€ 0) Unchanged
Bank debt	€ 18,986 Bank debt 2021: € 18,986 First fiscal year in the series	€ 55,170 Bank debt 2022: € 55,170 ▲ 191% vs 2021 (€ 18,986) Unfavourable step	€ 53,750 Bank debt 2023: € 53,750 ▼ 3% vs 2022 (€ 55,170) Favourable step	€ 52,813 Bank debt 2024: € 52,813 ▼ 2% vs 2023 (€ 53,750) Favourable step	▼ 2%
Balance sheet total	€ 188,755 Balance sheet total 2021: € 188,755 First fiscal year in the series	€ 246,932 Balance sheet total 2022: € 246,932 ▲ 31% vs 2021 (€ 188,755) Unchanged	€ 277,864 Balance sheet total 2023: € 277,864 ▲ 13% vs 2022 (€ 246,932) Unchanged	€ 332,428 Balance sheet total 2024: € 332,428 ▲ 20% vs 2023 (€ 277,864) Unchanged	▲ 20%
Employees (FTE)	0.9 Employees (FTE) 2021: 0.9 First fiscal year in the series	0.9 Employees (FTE) 2022: 0.9 Unchanged (0.9) Unchanged	0.9 Employees (FTE) 2023: 0.9 Unchanged (0.9) Unchanged	0.9 Employees (FTE) 2024: 0.9 Unchanged (0.9) Unchanged

Key figures of APOTHEEK KROONPLEIN, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to APOTHEEK KROONPLEIN?

What happened at APOTHEEK KROONPLEIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2025 New annual accounts for financial year 2024: profit of € 66,435 (▲ € 53,389 vs 2023). filed late Source: NBB ↗
Apr 19, 1990 New establishment in Antwerpen. KBO
Nov 16, 1989 Start of the company according to the CBE. KBO

In short

From € 51,563 profit in 2021 to € 66,435 profit in 2024.

Paid € 29,255 in corporate taxes since 2021.

Best year ever: 2024, with € 66,435 profit.

Paid out € 75,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

GOVEMED 100%

APOTHEEK GORTZ 0.2%

The stake of GOVEMED, APOTHEEK GORTZ comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK KROONPLEIN

Behind APOTHEEK KROONPLEIN is Govemed BV. The shares are held by GOVEMED (100%) and APOTHEEK GORTZ (0.2%).

Directors

According to the 2024 annual accounts

Govemed BV

Director · represented by Victor Görtz

Also active at: APOTHEEK GORTZ

Shareholders

GOVEMED

100%

APOTHEEK GORTZ

0.2%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kroonplein 47

2170 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekkroonplein.be

Technologies

BootstrapChart.jsCloudflare CDNDiviElementorFacebook PixelFont AwesomeGoogle FontsPHPSwiperWP RocketWPMLWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Website info

HTTPS Ja

Languages EN

Features

Webshop Blog Ads Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0440.018.823

VAT number

BE 0440.018.823

Registered office

Kroonplein 47, 2170 Antwerpen

Names & denominations

APOTHEEK KROONPLEIN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

16 November 1989

Peppol

Active · Active since 1 Jan 2001

Contact

apotheekkroonplein.be [email protected] 036458820

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK KROONPLEIN

Financials

What happened to APOTHEEK KROONPLEIN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions